Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01482052
What this trial is testing

Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 60
Early research (Phase 1)Study completedNCT03425149
What this trial is testing

Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults

Who this might be right for
Zika VirusZika Virus Infection
Valneva Austria GmbH 67
Early research (Phase 1)Study completedNCT00943358
What this trial is testing

Safety and Immunogenicity of A/H1N1v Vaccines in Healthy Adults

Who this might be right for
Influenza
University Hospitals, Leicester 175
Large-scale testing (Phase 3)Study completedNCT05642078
What this trial is testing

Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split Vaccine

Who this might be right for
Prevention of Influenza
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 2,550
Large-scale testing (Phase 3)Study completedNCT04707391
What this trial is testing

Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,250
Testing effectiveness (Phase 2)Study completedNCT01734408
What this trial is testing

A Booster Dose of Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children

Who this might be right for
EV71-associated Disease
Jiangsu Province Centers for Disease Control and Prevention 773
Testing effectiveness (Phase 2)Study completedNCT02946190
What this trial is testing

The PertADO Geneva Trial

Who this might be right for
Pertussis
Siegrist Claire-Anne 60
Early research (Phase 1)Not Yet RecruitingNCT07374510
What this trial is testing

Phase Ia Clinical Trial of Group ACYW135X Meningococcal Conjugate Vaccine

Who this might be right for
Meningococcal Meningitis
Sinovac Life Sciences Co., Ltd. 150
Large-scale testing (Phase 3)Study completedNCT03947138
What this trial is testing

GC3107(BCG Vaccine) in Healthy Infants

Who this might be right for
BCG Vaccination ReactionTuberculosis
Green Cross Corporation 750
Large-scale testing (Phase 3)Study completedNCT00652938
What this trial is testing

Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 744
Not applicableStudy completedNCT06381843
What this trial is testing

A Clinical Study to Evaluate the Safety and Immunogenicity of the Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster

Who this might be right for
COVID-19SARS-CoV-2 Infection
WestVac Biopharma Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT00748813
What this trial is testing

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2008/2009

Who this might be right for
Seasonal Influenza
Novartis Vaccines 133
Not applicableStudy completedNCT01135082
What this trial is testing

Pneumococcal Conjugate Vaccine (PCV) in HIV- Infected Children

Who this might be right for
HIV
The HIV Netherlands Australia Thailand Research Collaboration 90
Large-scale testing (Phase 3)WithdrawnNCT02100618
What this trial is testing

Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT00551915
What this trial is testing

The Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003)

Who this might be right for
Bacterial Infections; Virus Diseases
Merck Sharp & Dohme LLC 756
Testing effectiveness (Phase 2)Active Not RecruitingNCT01088789
What this trial is testing

Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 71
Early research (Phase 1)Study completedNCT02496897
What this trial is testing

Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B

Who this might be right for
Hepatitis B
Altimmune, Inc. 61
Testing effectiveness (Phase 2)Study completedNCT05734040
What this trial is testing

Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.

Who this might be right for
Influenza
Osivax 478
Testing effectiveness (Phase 2)Study completedNCT03026348
What this trial is testing

Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Aluminum Phosphate or Matrix-M1™ Adjuvants In Clinically-Stable Older Adults

Who this might be right for
Respiratory Syncytial Viruses
Novavax 300
Post-approval studies (Phase 4)Study completedNCT00310635
What this trial is testing

Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age

Who this might be right for
Meningococcal Infection
Novartis 241
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation